Abstract
Dramatic price reductions make antiretroviral drugs increasingly affordable in Africa. However, poor infrastructure, conflicting interests, and lack of commitment to a common strategy could keep them beyond the reach of most infected people. Recent experiences in Kenya, where the political will exists, show the complexity of turning this opportunity into safe and effective practice.
| Original language | English |
|---|---|
| Pages (from-to) | 51-53 |
| Number of pages | 3 |
| Journal | The Lancet Infectious Diseases |
| Volume | 2 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2002 |